MacLellan nor the Aussies have the resources to update the test. It's why the stock was allowed to be bought up by someone that does. And since Arima/Uni apparently have the money, the medical talent, and a huge pool of people that will benefit from the it, it only makes sense that they purchased the shares as well. They are going public next year.